ANBT
PFE icon

American National Bank & Trust’s Pfizer PFE Stock Holding History

American National Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$536K Buy
22,270
+75
+0.3% +$1.96K 0.05% 153
2026
Q1 		$623K Sell
22,195
-1,982
-8% -$52.8K 0.06% 137
2025
Q4 		$602K Sell
24,177
-511
-2% -$12.9K 0.06% 143
2025
Q3 		$629K Sell
24,688
-5,875
-19% -$145K 0.06% 135
2025
Q2 		$741K Sell
30,563
-290
-0.9% -$6.76K 0.08% 131
2025
Q1 		$782K Sell
30,853
-81,866
-73% -$2.14M 0.09% 109
2024
Q4 		$2.99M Buy
112,719
+2,893
+3% +$78.5K 0.33% 55
2024
Q3 		$3.18M Sell
109,826
-2,657
-2% -$77.5K 0.37% 55
2024
Q2 		$3.15M Sell
112,483
-655
-0.6% -$18K 0.39% 53
2024
Q1 		$3.14M Buy
113,138
+57,051
+102% +$1.58M 0.42% 55
2023
Q4 		$1.61M Sell
56,087
-141,646
-72% -$4.28M 0.25% 72
2023
Q3 		$6.56M Buy
197,733
+7,774
+4% +$275K 1.12% 31
2023
Q2 		$6.97M Sell
189,959
-59,373
-24% -$2.31M 1.17% 32
2023
Q1 		$10.2M Buy
249,332
+54,803
+28% +$2.37M 1.88% 13
2022
Q4 		$9.97M Sell
194,529
-979
-0.5% -$46.9K 2.05% 13
2022
Q3 		$8.55M Sell
195,508
-8,671
-4% -$421K 2.05% 13
2022
Q2 		$10.7M Sell
204,179
-3,599
-2% -$183K 2.56% 10
2022
Q1 		$10.8M Sell
207,778
-15,198
-7% -$789K 2.14% 11
2021
Q4 		$13.2M Sell
222,976
-2,326
-1% -$115K 2.57% 8
2021
Q3 		$9.69M Sell
225,302
-871
-0.4% -$38.6K 2.15% 11
2021
Q2 		$8.86M Sell
226,173
-5,115
-2% -$199K 1.9% 17
2021
Q1 		$8.38M Buy
231,288
+63,498
+38% +$2.25M 1.98% 18
2020
Q4 		$6.18M Sell
167,790
-18,711
-10% -$686K 1.59% 24
2020
Q3 		$6.49M Buy
186,501
+23,239
+14% +$815K 1.85% 22
2020
Q2 		$5.07M Sell
163,262
-18,310
-10% -$622K 1.63% 27
2020
Q1 		$5.62M Buy
181,572
+94,768
+109% +$3.23M 2.21% 18
2019
Q4 		$3.23M Sell
86,804
-1,355
-2% -$48.3K 0.95% 42
2019
Q3 		$3M Sell
88,159
-90,472
-51% -$3.29M 0.93% 41
2019
Q2 		$7.34M Sell
178,631
-16,212
-8% -$644K 2.32% 10
2019
Q1 		$7.85M Buy
194,843
+4,277
+2% +$171K 2.48% 9
2018
Q4 		$7.89M Buy
190,566
+431
+0.2% +$17.9K 2.88% 5
2018
Q3 		$7.95M Buy
190,135
+12,463
+7% +$480K 2.29% 9
2018
Q2 		$6.12M Sell
177,672
-10,033
-5% -$343K 1.75% 14
2018
Q1 		$6.32M Buy
187,705
+3,224
+2% +$111K 1.82% 12
2017
Q4 		$6.34M Buy
184,481
+11,265
+7% +$384K 1.79% 18
2017
Q3 		$5.87M Buy
173,216
+9,813
+6% +$315K 1.76% 16
2017
Q2 		$5.21M Buy
163,403
+1,035
+0.6% +$32.6K 1.67% 21
2017
Q1 		$5.27M Sell
162,368
-1,259
-0.8% -$39.7K 1.64% 20
2016
Q4 		$5.04M Sell
163,627
-15,313
-9% -$467K 1.65% 19
2016
Q3 		$5.75M Buy
178,940
+9,375
+6% +$313K 1.92% 17
2016
Q2 		$5.67M Buy
169,565
+1,356
+0.8% +$43.3K 2.07% 12
2016
Q1 		$4.73M Buy
168,209
+17,490
+12% +$500K 1.78% 19
2015
Q4 		$4.62M Buy
150,719
+3,213
+2% +$101K 1.79% 17
2015
Q3 		$4.4M Buy
147,506
+179
+0.1% +$5.74K 1.87% 16
2015
Q2 		$4.69M Sell
147,327
-35,184
-19% -$1.15M 1.87% 17
2015
Q1 		$6.02M Buy
182,511
+4,587
+3% +$146K 2.33% 13
2014
Q4 		$5.26M Sell
177,924
-2,843
-2% -$81.5K 2.01% 15
2014
Q3 		$5.07M Sell
180,767
-875
-0.5% -$24.6K 1.97% 14
2014
Q2 		$5.11M Sell
181,642
-1,222
-0.7% -$34.8K 1.92% 15
2014
Q1 		$5.57M Sell
182,864
-983
-0.5% -$29.3K 2.23% 10
2013
Q4 		$5.34M Sell
183,847
-10,928
-6% -$318K 2.14% 14
2013
Q3 		$5.31M Buy
194,775
+3,288
+2% +$89.5K 2.26% 13
2013
Q2 		$5.09M Buy
+191,487
New +$5.29M 2.27% 15

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

American National Bank & Trust's PFE Position: Q2 2026 in Review

American National Bank & Trust increased its Pfizer (PFE) stake by 0.34% in Q2 2026, buying an estimated $1.96K and bringing the position to 22,270 shares worth $536K. The position accounts for 0.05% of the portfolio, ranked #153.

American National Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.2M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • American National Bank & Trust held 22,270 shares of Pfizer worth $536K as of Q2 2026.
  • American National Bank & Trust bought 75 Pfizer shares in Q2 2026, an estimated $1.96K.
  • Pfizer made up 0.05% of American National Bank & Trust's portfolio in Q2 2026, its #153 holding.
  • American National Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • American National Bank & Trust's Pfizer position peaked at $13.2M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.